S. J. Jacobus	No disclosures Contributions: ABCDE
S. Kumar	Clinical Trial Support - Celgene, Millennium, Genzyme, Novartis, Cephalon; Consultant Merck Contributions: ABCDE
S.A. Van Wier	No disclosures Contributions: AC
G.J. Ahmann	No disclosures Contributions: AC
K.J. Henderson	No disclosures Contributions: AC
N.S. Callander	No disclosures Contributions: ABCD
M.E. Williams	Celgene clinical trial research funding; consultant and Member of a Celgene clinical trial Data Safety Committee (total compensation <$10,000). Cephalon, Genentech, Millennium, Novartis: clinical trial research funding. Contributions: A
D.S. Siegel	Celgene Honoraria/Speakers Bureau/Research Support Millennium Honoraria/Speakers Bureau; Onyx-Honoraria Contributions: A
P.R. Greipp	No disclosures Contributions: ABCDE
S.V. Rajkumar	No disclosures Contributions: ABCDE
H. Uno	No disclosures Contributions: ABCDE
R. Fonseca	Patent for prognostication of MM based on genetic categorization of the disease. Consulting fees from Medtronic, Otsuka, Celgene, Genzyme, BMS and Amgen. Research funding from Cylene, Onyx. Contributions: ABCDE